Marlowe has raised £131m through a share placing to fund the earnings enhancing acquisition of Optima Health, which will position Marlowe as the clear market leader in the fragmented UK occupational health industry (9% market share). Marlowe is paying 9.6x expected 2022 synergised EBITDA for the business, which we believe represents an attractive multiple, given the target's strong organic growth rates (12% revenue CAGR over the past two years), sticky customer base (9-year average relationship ....
21 Jan 2022
Cenkos: Marlowe Plc -- Transformational acquisition & share placing
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Cenkos: Marlowe Plc -- Transformational acquisition & share placing
Marlowe Plc (MRL:LON) | 536 85.8 3.1% | Mkt Cap: 518.7m
- Published:
21 Jan 2022 -
Author:
Peter Renton -
Pages:
9
Marlowe has raised £131m through a share placing to fund the earnings enhancing acquisition of Optima Health, which will position Marlowe as the clear market leader in the fragmented UK occupational health industry (9% market share). Marlowe is paying 9.6x expected 2022 synergised EBITDA for the business, which we believe represents an attractive multiple, given the target's strong organic growth rates (12% revenue CAGR over the past two years), sticky customer base (9-year average relationship ....